BOAN BIOTECH(06955),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

06955 BOAN BIOTECH

Trading 01-28 14:40:42

8.750

-0.030

-0.34%

High8.870	Low8.700	Vol1.25M
Open8.790	D1 Closing8.780	Amplitude1.94%
Mkt Cap5.44B	Tradable Cap5.45B	Total Shares622.00M
T/O10.96M	T/O Rate0.20%	Tradable Shares622.33M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"06955","market":"HK","secType":"STK","nameCN":"BOAN BIOTECH","latestPrice":8.75,"timestamp":1769582334352,"preClose":8.78,"halted":0,"volume":1251800,"delay":0,"changeRate":-0.0034168564920272625,"floatShares":622333694,"shares":622000000,"eps":0.136563,"marketStatus":"Trading","change":-0.03,"latestTime":"01-28 14:40:42","open":8.79,"high":8.87,"low":8.7,"amount":10956616,"amplitude":0.019362,"askPrice":8.76,"askSize":43000,"bidPrice":8.74,"bidSize":5200,"shortable":3,"etf":0,"ttmEps":0.056346,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1769587800000},"marketStatusCode":2,"adr":0,"listingDate":1672329600000,"exchange":"SEHK","adjPreClose":8.78,"openAndCloseTimeList":[[1769563800000,1769572800000],[1769576400000,1769587200000]],"volumeRatio":0.117317,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06955","defaultTab":"news","newsList":[{"id":"1123106870","title":"BOAN BIOTECH (06955) Shareholder Transfers Shares from China Securities Depository and Clearing Hong Kong to CITIC SEC Brokerage Hong Kong, Portfolio Value of HK$346 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1123106870","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123106870?lang=en_us&edition=fundamental","pubTime":"2026-01-27 08:56","pubTimestamp":1769475381,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on January 26, a shareholder of BOAN BIOTECH (06955) transferred shares from China Securities Depository and Clearing Hong Kong to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2495084118.USD","LU1720050803.USD","BK0028","LU0405327494.USD","BK0183","LU1997245094.SGD","BK1564","BK0276","LU1328615791.USD","BK0196","LU0405327148.USD","LU1997245177.USD","BK1516","LU1255011170.USD","BK1161","LU1997244956.HKD","LU1064130708.USD","LU1064131003.USD","06955","161027","LU1794554557.SGD","BK0012","BK0188","LU2289578879.USD","LU1655091616.SGD","LU2148510915.USD","BK1521","600030","06030","BK1147"],"gpt_icon":0},{"id":"1139519339","title":"BOAN BIOTECH (06955) Controlling Shareholder Plans Further Transfer of 11.9866 Million H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1139519339","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139519339?lang=en_us&edition=fundamental","pubTime":"2026-01-26 22:10","pubTimestamp":1769436656,"startTime":"0","endTime":"0","summary":"The Board of Directors of BOAN BIOTECH (06955) has been notified by its controlling shareholder, Luye Pharma Group, that pursuant to the terms of a subscription agreement related to exchangeable...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2606245438","title":"Shandong Boan Biotechnology Transfers 11.99 Million H Shares to Complete Minority Stake Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2606245438","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606245438?lang=en_us&edition=fundamental","pubTime":"2026-01-26 22:01","pubTimestamp":1769436073,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotechnology Co. Ltd. has announced that its controlling shareholder, Luye Pharma Group Ltd., through its wholly-owned subsidiary Shandong Luye Pharmaceutical Co., Ltd., will transfer 11,986,600 H shares of Boan Biotechnology to the Issuer on 27 January 2026. This transfer is part of the completion of a previously announced proposed transfer, in accordance with the terms of a subscription agreement related to Exchangeable Preference Shares. The board of Boan Biotechnology does not expect the transaction to have any material adverse effect on the group’s business operations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Boan Biotechnology Co. Ltd. published the original content used to generate this news brief v","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDLbl2mT3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186","BK1583","06955","BK1191","BK1161","BK1606"],"gpt_icon":0},{"id":"1127306625","title":"BOAN BIOTECH (06955): Shandong Luye Pharmaceutical Plans Further Transfer of 38.5 Million H Shares to Luye Geneora Holding","url":"https://stock-news.laohu8.com/highlight/detail?id=1127306625","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127306625?lang=en_us&edition=fundamental","pubTime":"2026-01-21 22:14","pubTimestamp":1769004855,"startTime":"0","endTime":"0","summary":"The Board of Directors of BOAN BIOTECH (06955) has been notified by its controlling shareholder, LUYE PHARMA Group, that, pursuant to the terms of a subscription agreement related to exchangeable...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06955","BK1161","BK1606","BK1583","02186","BK1191"],"gpt_icon":0},{"id":"2605488308","title":"Shandong Boan Biotechnology Transfers 38.5 Million H Shares to New Investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2605488308","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605488308?lang=en_us&edition=fundamental","pubTime":"2026-01-21 22:06","pubTimestamp":1769004367,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotechnology Co. Ltd. announced that its controlling shareholder, Luye Pharma Group Ltd., through its wholly-owned subsidiary Shandong Luye Pharmaceutical Co., Ltd., will transfer 38,500,000 H Shares of Shandong Boan Biotechnology to the Issuer on January 22, 2026. This transfer is part of a previously disclosed arrangement under a subscription agreement related to Exchangeable Preference Shares. The board of Shandong Boan Biotechnology does not expect the transaction to have any material adverse effect on the company’s business operations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Boan Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Ser","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL9pWGGv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186","BK1191","BK1606","06955","BK1583","BK1161"],"gpt_icon":0},{"id":"2603610377","title":"BRIEF-Shandong Boan Biotechnology Will Lease Assets At Purchase Price Of RMB41.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2603610377","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603610377?lang=en_us&edition=fundamental","pubTime":"2026-01-14 23:32","pubTimestamp":1768404769,"startTime":"0","endTime":"0","summary":"BRIEF-Shandong Boan Biotechnology Will Lease Assets At Purchase Price Of RMB41.1 MillionJan 14  - Shandong Boan Biotechnology Co Ltd 6955.HK:CO WILL LEASE LEASED ASSETS AT A PURCHASE PRICE OF RMB41.1 MILLIONLEASED ASSETS REFER TO CERTAIN MACHINERY AND EQUIPMENTFurther company coverage: 6955.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YF1S0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06955"],"gpt_icon":0},{"id":"1174074501","title":"BOAN BIOTECH (06955) Enters into Financial Lease Agreement with Industrial Financial Leasing","url":"https://stock-news.laohu8.com/highlight/detail?id=1174074501","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174074501?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:34","pubTimestamp":1768397653,"startTime":"0","endTime":"0","summary":"BOAN BIOTECH (06955) announced that on January 14, 2026, the company entered into a financial lease agreement with Industrial Financial Leasing. Under this agreement, Industrial Financial Leasing...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2603937619","title":"Shandong Boan Biotechnology - Co Will Lease Leased Assets at a Purchase Price of RMB41.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2603937619","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603937619?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:31","pubTimestamp":1768397513,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YF1S0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2603761995","title":"Shandong Boan Biotechnology - Leased Assets Refer to Certain Machinery and Equipment","url":"https://stock-news.laohu8.com/highlight/detail?id=2603761995","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603761995?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:31","pubTimestamp":1768397513,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YF1S0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2603619976","title":"Shandong Boan Biotechnology Signs Finance Lease Agreement with Industrial Bank Financial Leasing","url":"https://stock-news.laohu8.com/highlight/detail?id=2603619976","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603619976?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:31","pubTimestamp":1768397502,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotechnology Co. Ltd. has entered into a new finance lease agreement with Industrial Bank Financial Leasing on January 14, 2026. Under the agreement, Industrial Bank Financial Leasing will purchase and lease certain machinery and equipment to Shandong Boan Biotechnology. The company stated that the terms of the finance lease agreement were reached after arm's length negotiations and are considered fair and reasonable. This new agreement is separate from a previous finance lease agreement signed between the two parties in January 2025, which involved different assets. The arrangement is expected to support Shandong Boan Biotechnology’s business activities and strategic goals in both domestic and international markets.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDL45nxNW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601166","BK1161","BK0015","BK0012","LU1580142542.USD","HK0000181138.USD","06955","LU0821914370.USD","LU0264606111.USD","BK1191","LU0572940350.SGD","BK1606","BK0188","02186","LU1328615791.USD","BK1583","BK0183","BK0187","BK0028","HK0000181112.HKD","LU0572939691.SGD","BK0278","LU1048596156.SGD","LU1781817850.SGD"],"gpt_icon":0},{"id":"1152800548","title":"BOAN BIOTECH (06955) Surges Over 6% as Denosumab Injection Gains Approval in Bolivia, Plans to Submit Marketing Applications in Multiple Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=1152800548","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152800548?lang=en_us&edition=fundamental","pubTime":"2026-01-13 10:20","pubTimestamp":1768270823,"startTime":"0","endTime":"0","summary":"BOAN BIOTECH (06955) rose more than 6%. At the time of writing, the stock was up 6.28%, trading at HKD 9.98, with a turnover of HKD 49.8845 million. On the news front, on January 11, BOAN BIOTECH...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06955","BK1161"],"gpt_icon":0},{"id":"1165089686","title":"Zhutong Hong Kong Stock Shareholder Equity Disclosures | January 12","url":"https://stock-news.laohu8.com/highlight/detail?id=1165089686","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165089686?lang=en_us&edition=fundamental","pubTime":"2026-01-12 08:08","pubTimestamp":1768176533,"startTime":"0","endTime":"0","summary":"On January 12, 2026, ZHONG JIA GX (00899), BOAN BIOTECH (06955), FUDANZHANGJIANG (01349), FORTUNE REIT (00778), SSY GROUP (02005), and YESASIA HLDGS (02209) made their latest shareholder equity...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1142","02005","BK1191","BK1114","BK1098","01349","BK1240","00899","02209","06955","BK1587","LU2460026573.USD","00778","BK1161","BK1256"],"gpt_icon":0},{"id":"1193519826","title":"BOAN BIOTECH (06955): Abnormal Trading Volume Movement and Denosumab (60MG) Approved for Market Launch in Bolivia","url":"https://stock-news.laohu8.com/highlight/detail?id=1193519826","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193519826?lang=en_us&edition=fundamental","pubTime":"2026-01-11 18:30","pubTimestamp":1768127440,"startTime":"0","endTime":"0","summary":"The Board of Directors of the Company has noted an increase in the trading volume of the Company's H shares on January 9, 2026. After making reasonable enquiries under the circumstances, the Board...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2602603555","title":"Shandong Boan Biotechnology Clarifies Denosumab Approval in Bolivia and Trading Volume Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2602603555","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602603555?lang=en_us&edition=fundamental","pubTime":"2026-01-11 18:16","pubTimestamp":1768126571,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotechnology Co. Ltd. issued a clarification regarding unusual trading volume of its shares on January 9, 2026. The company's board stated that, aside from the voluntary disclosure about the approval of Denosumab  for marketing in Bolivia, it is not aware of any reasons for the unusual trading activity, any information that must be announced to avoid a false market, or any inside information that needs to be disclosed under relevant regulations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Boan Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on January 11, 2026, and is solely responsible f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260111:nNDL9hbSPs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06955"],"gpt_icon":0},{"id":"2591169209","title":"Luye Pharma Unit Completes Sale of Boan Biotech-Linked Exchangeable Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2591169209","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591169209?lang=en_us&edition=fundamental","pubTime":"2025-12-15 13:06","pubTimestamp":1765775210,"startTime":"0","endTime":"0","summary":"Luye Pharma Group (HKG:2186) said a wholly owned unit completed the issue of $150 million in exchangeable preference shares to an independent subscriber, according to a Hong Kong bourse filing Friday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02186","06955","BK1161","BK1191","BK1583","BK1606"],"gpt_icon":0},{"id":"2588008575","title":"Shandong Boan Biotechnology Co., Ltd. (HKG:6955) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?","url":"https://stock-news.laohu8.com/highlight/detail?id=2588008575","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588008575?lang=en_us&edition=fundamental","pubTime":"2025-12-04 07:02","pubTimestamp":1764802935,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotechnology (HKG:6955) has had a rough three months with its share price down 27%. However, stock...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6955/shandong-boan-biotechnology-shares/news/shandong-boan-biotechnology-co-ltd-hkg6955-stocks-been-slidi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6955/shandong-boan-biotechnology-shares/news/shandong-boan-biotechnology-co-ltd-hkg6955-stocks-been-slidi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","06955"],"gpt_icon":0},{"id":"1124932540","title":"Shandong Boan Biotechnology (06955) Releases Monthly Return for November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1124932540","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124932540?lang=en_us&edition=fundamental","pubTime":"2025-12-03 16:55","pubTimestamp":1764752136,"startTime":"0","endTime":"0","summary":"Shandong Boan Biotechnology Co., Ltd. (06955) submitted its monthly return for the month ended 30 November 2025. According to the document, the company’s registered share capital stood at RMB...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06955"],"gpt_icon":0},{"id":"1113894742","title":"BOAN BIOTECH (06955) Rises Nearly 7% in Early Trading as Aflibercept Ophthalmic Injection Solution Gains NMPA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113894742","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113894742?lang=en_us&edition=fundamental","pubTime":"2025-11-27 09:38","pubTimestamp":1764207502,"startTime":"0","endTime":"0","summary":"BOAN BIOTECH (06955) surged nearly 7% in early trading, with gains moderating to 4.3% at the time of writing, reaching HK$10.91 and a turnover of HK$21.45 million. On November 26, BOAN BIOTECH...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06955","BK1161"],"gpt_icon":0},{"id":"2586533002","title":"BRIEF-Shandong Boan Biotechnology Says Boyoujing Approved For Marketing In China By NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2586533002","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586533002?lang=en_us&edition=fundamental","pubTime":"2025-11-26 18:17","pubTimestamp":1764152231,"startTime":"0","endTime":"0","summary":"BRIEF-Shandong Boan Biotechnology Says Boyoujing Approved For Marketing In China By NMPANov 26 (Reuters) - Shandong Boan Biotechnology Co Ltd 6955.HK:BOYOUJING APPROVED FOR MARKETING IN CHINA BY NMPAFurther company coverage: 6955.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nFWN3X20JL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06955","BK1161"],"gpt_icon":0},{"id":"1175570142","title":"BOAN BIOTECH (06955): Aflibercept Ophthalmic Injection Solution Boyoujing® Approved for Launch in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1175570142","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175570142?lang=en_us&edition=fundamental","pubTime":"2025-11-26 17:50","pubTimestamp":1764150644,"startTime":"0","endTime":"0","summary":"BOAN BIOTECH (06955) announced that its self-developed Boyoujing® (aflibercept ophthalmic injection solution) has officially received marketing approval from China's National Medical Products...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06955"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.boan-bio.com","stockEarnings":[{"period":"1week","weight":-0.0309},{"period":"1month","weight":-0.0023},{"period":"3month","weight":-0.155},{"period":"6month","weight":-0.4925},{"period":"1year","weight":0.0092},{"period":"ytd","weight":0.0281}],"compareEarnings":[{"period":"1week","weight":0.0241},{"period":"1month","weight":0.0507},{"period":"3month","weight":0.0296},{"period":"6month","weight":0.095},{"period":"1year","weight":0.3431},{"period":"ytd","weight":0.0584}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Shandong Boan Biotechnology Co Ltd is a China-based company primarily engaged in biopharmaceuticals. The Company is engaged in the development, production and commercialisation of therapeutic antibodies, focusing on the therapeutic areas of oncology, metabolism, autoimmunology and ophthalmology. The Company has three main technology platforms: a fully human antibody transgenic mouse and phage display technology platform, a bispecific T-cell Engager technology platform, and an antibody drug coupling (ADC) technology platform. The Company operates mainly in the domestic Chinese market and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.147991},{"month":2,"riseRate":0.666667,"avgChangeRate":0.021825},{"month":3,"riseRate":0.333333,"avgChangeRate":0.047525},{"month":4,"riseRate":0.666667,"avgChangeRate":0.053695},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.022243},{"month":6,"riseRate":0.333333,"avgChangeRate":0.003308},{"month":7,"riseRate":0.666667,"avgChangeRate":0.172102},{"month":8,"riseRate":0,"avgChangeRate":-0.097114},{"month":9,"riseRate":0.666667,"avgChangeRate":0.038827},{"month":10,"riseRate":0,"avgChangeRate":-0.109251},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.02386},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.011932}],"exchange":"SEHK","name":"BOAN BIOTECH","nameEN":"BOAN BIOTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BOAN BIOTECH(06955),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BOAN BIOTECH(06955) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BOAN BIOTECH,06955,BOAN BIOTECH股票,BOAN BIOTECH股票老虎,BOAN BIOTECH股票老虎国际,BOAN BIOTECH行情,BOAN BIOTECH股票行情,BOAN BIOTECH股价,BOAN BIOTECH股市,BOAN BIOTECH股票价格,BOAN BIOTECH股票交易,BOAN BIOTECH股票购买,BOAN BIOTECH股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BOAN BIOTECH(06955),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BOAN BIOTECH(06955) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}